IDiyas

For the Inventor, By the Inventor

FR

Ethypharm, Inc.


USPTO Granted Patents = 42



Trademarks = 4

Forward Citations = 572

Loading Chart...
Loading Chart...

122 inventors (with patents filed for the assignee):

goldMedal Catherine Herry (10 out of 11 patents)

silverMedal Pascal Oury (9 out of 19 patents)

bronzeMedal Philippe Chenevier (9 out of 9 patents)

4.  Pascal Suplie (7 out of 23 patents)

5.  Dominique Marechal (6 out of 6 patents)

6.  Bruno Criere (6 out of 6 patents)

7.  Edouard Gendrot (3 out of 8 patents)

8.  Charles Chauveau (3 out of 5 patents)

9.  Jean-Marc Zuccarelli (3 out of 4 patents)

10.  Patrice Debregeas (3 out of 12 patents)

11.  Caroline Ailhas (2 out of 2 patents)

12.  Yann Prevost (2 out of 2 patents)

13.  George Bobotas (2 out of 10 patents)

14.  Vincent Billoet (2 out of 2 patents)

15.  Mahendra B Chaudhari (2 out of 2 patents)


42 patents:

1. 11872306 - Granules of an active substance with double taste-masking technique, method for the production thereof, and orodispersible tablets containing same (2024-01-16),
2. 10987309 - Tablet capable of combatting misuse by injection (2021-04-27),
3. 10258692 - Oral pharmaceutical formulation of BCS class III molecules (2019-04-16),
4. 10111869 - Reduction of opioid blood fluctuations (2018-10-30),
5. 10111832 - Orodispersible tablets obtained by compression molding (2018-10-30),
6. 9993431 - Diversion-resistant microgranules and microtablets (2018-06-12),
7. 9877925 - Alcohol-resistant oral pharmaceutical form (2018-01-30),
8. 9629800 - Gastroretentive formulations and manufacturing process thereof (2017-04-25),
9. 9616071 - Oral sustained release pharmaceutical composition (2017-04-11),
10. 9603797 - Oral and/or buccal composition in the form of a thin film of a weakly soluble active ingredient, method of preparing same and use of same (2017-03-28),
11. 9492397 - Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules (2016-11-15),
12. 9446002 - Spheroids and multiparticulate tablets comprising them (2016-09-20),
13. 8865219 - Orodispersible tablets of bitter active principles (2014-10-21),
14. 8815944 - Pharmaceutical composition with gelling properties containing a tyrosine derivative (2014-08-26),
15. 8709479 - Sublingual coated tablet of fentanyl (2014-04-29),
Ethypharm, Inc. is a global pharmaceutical company focused on developing and commercializing innovative medication solutions for the treatment of patients with complex and chronic conditions. With a strong emphasis on research, development, and regulatory expertise, Ethypharm strives to bring specialized medications to market that improve patients' health and quality of life. Collaborating with healthcare professionals, partners, and patients, Ethypharm aims to address unmet medical needs and make a positive impact on the well-being of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
42 Patents

#32 in

#526 in France

#15,845 in the World

...
FR

Ethypharm, Inc.

Forward Citations = 572

122 inventors:

goldMedal Catherine Herry (10 out of 11 patents)

silverMedal Pascal Oury (9 out of 19 patents)

bronzeMedal Philippe Chenevier (9 out of 9 patents)

4.  Pascal Suplie (7 out of 23 patents)

5.  Dominique Marechal (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…